| ELRANATAMAB |
Elrexfio® |
PFIZER AUSTRALIA PTY LTD |
Relapsed or refractory multiple myeloma (RRMM) |
Jul 2024 |
Not Recommended |
| SELPERCATINIB |
Retevmo® |
ELI LILLY AUSTRALIA PTY LTD |
Non-small cell lung cancer (NSCLC) |
Jul 2024 |
Recommended |
| NIVOLUMAB; IPILIMUMAB |
|
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD |
Unresectable malignant mesothelioma |
Jul 2024 |
Not Recommended |
| PROGESTERONE |
Utrogestan® |
BESINS HEALTHCARE AUSTRALIA PTY LTD |
Luteal phase support |
Jul 2024 |
Recommended |
| BLINATUMOMAB |
Blincyto® |
AMGEN AUSTRALIA PTY LIMITED |
Measurable residual disease (MRD)-negative B-cell precursor acute lymphoblastic leukaemia
(B-ALL) |
Jul 2024 |
Deferred |
| MILK POWDER -- SYNTHETIC |
Locasol® |
NUTRICIA AUSTRALIA PTY LIMITED |
Hypercalcaemia |
Jul 2024 |
Recommended |
| APALUTAMIDE |
Erlyand® |
JANSSEN-CILAG PTY LTD |
Non-metastatic castration-resistant carcinoma of the prostate Metastatic castration-sensitive
carcinoma of the prostate |
Jul 2024 |
Recommended |
| ZILUCOPLAN |
Zilbrysq® |
UCB AUSTRALIA PROPRIETARY LIMITED |
Generalised myasthenia gravis (gMG) |
Jul 2024 |
Not Recommended |
| ODEVIXIBAT |
Bylvay® |
IPSEN PTY LTD |
Progressive familial intrahepatic cholestasis (PFIC) |
Jul 2024 |
Not Recommended |
| ARIPIPRAZOLE |
Abilify Asimtufii® |
LUNDBECK AUSTRALIA PTY LTD |
Schizophrenia |
Jul 2024 |
Not Applicable |
| METHOTREXATE |
Methoblastin® |
PFIZER AUSTRALIA PTY LTD |
Chemotherapy and inflammatory conditions |
Jul 2024 |
Recommended |
| DIENOGEST |
Visanne® |
BAYER AUSTRALIA LTD |
Endometriosis |
Jul 2024 |
Recommended |
| ADALIMUMAB |
Hyrimoz® |
SANDOZ PTY LTD |
Severe Crohn disease (CD) Moderate to severe ulcerative colitis (UC) Severe active
juvenile idiopathic arthritis (JIA) Complex refractory fistulising Crohn disease (CD)
Severe active rheumatoid arthritis (RA) Severe psoriatic arthritis (PsA) Ankylosing
spondylitis (AS) Severe chronic plaque psoriasis (CPP) Moderate to severe hidradenitis
suppurativa (HS) |
Jul 2024 |
Recommended |
| LANREOTIDE |
Somatuline® Autogel |
IPSEN PTY LTD |
Acromegaly Functional Carcinoid Tumour Non-functional gastroenteropancreatic neuroendocrine
tumour (GEP-NET) |
Jul 2024 |
Recommended |
| FRUQUINTINIB |
Fruzaqla® |
TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD. |
Metastatic colorectal cancer (mCRC) |
Jul 2024 |
Not Applicable |
| ESKETAMINE |
Spravato® |
JANSSEN-CILAG PTY LTD |
Treatment resistant depression |
Jul 2024 |
Deferred |
| LECANEMAB |
Leqembi® |
EISAI AUSTRALIA PTY LTD |
Early Alzheimer disease (EAD) |
Jul 2024 |
Not Applicable |
| ADRENALINE (EPINEPHRINE) |
Jext® Jnr; Jext® |
HEALTH TECHNOLOGY ANALYSTS PTY LIMITED |
Acute allergic reaction with anaphylaxis |
Jul 2024 |
Recommended |
| NIRSEVIMAB |
Beyfortus® |
SANOFI-AVENTIS AUSTRALIA PTY LTD |
Prevention of lower respiratory tract disease caused by respiratory syncytial virus
(RSV) |
Jul 2024 |
Not Recommended |
| BELZUTIFAN |
Welireg® |
MERCK SHARP & DOHME (AUSTRALIA) PTY LTD |
Von Hippel-Lindau (VHL) disease |
Jul 2024 |
Recommended |
| PROPYLENE GLYCOL |
Systane Balance® |
ALCON LABORATORIES (AUSTRALIA) PTY LTD |
Severe dry eye syndrome |
Jul 2024 |
Recommended |
| ESTRADIOL |
Sandrena® |
ORION PHARMA (AUS) PTY LIMITED |
Climacteric symptoms after natural or surgical menopause |
Jul 2024 |
Recommended |
| IPTACOPAN |
Fabhalta® |
NOVARTIS PHARMACEUTICALS AUSTRALIA PTY LIMITED |
Paroxysmal nocturnal hemoglobinuria (PNH) |
Jul 2024 |
Recommended |
| VEDOLIZUMAB |
Entyvio® |
TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD. |
Chronic pouchitis |
Jul 2024 |
Recommended |
| FARICIMAB |
Vabysmo® |
ROCHE PRODUCTS PTY LTD |
Retinal vein occlusion (RVO) |
Jul 2024 |
Recommended |
| ZANUBRUTINIB |
Brukinsa® |
BEIGENE AUS PTY LTD |
Waldenström macroglobulinaemia |
Jul 2024 |
Recommended |
| DROSPIRENONE WITH ETHINYLESTRADIOL |
Yaz®; Yasmin® |
BAYER AUSTRALIA LTD |
Oral contraceptive Moderate acne vulgaris in women who seek oral contraception Premenstrual
dysphoric disorder in women who have chosen oral contraceptives as their method of
birth control |
Jul 2024 |
Recommended |
| IVOSIDENIB |
Tibsovo® |
SERVIER LABORATORIES (AUST.) PTY. LTD. |
Bile duct cancer (cholangiocarcinoma) |
Jul 2024 |
Not Recommended |
| LINZAGOLIX |
Yselty® |
THERAMEX AUSTRALIA PTY LTD |
Moderate to severe symptomatic uterine fibroids |
Jul 2024 |
Not Recommended |
| OLAPARIB |
Lynparza® |
ASTRAZENECA PTY LTD |
Human epidermal growth factor 2 (HER2) negative metastatic breast cancer with a confirmed
BRCA1 or BRCA2 mutation |
Jul 2024 |
Recommended |
| RISDIPLAM |
Evrysdi® |
ROCHE PRODUCTS PTY LTD |
Spinal muscular atrophy (SMA) |
Jul 2024 |
Recommended |
| DAUNORUBICIN WITH CYTARABINE |
Vyxeos® |
JAZZ PHARMACEUTICALS ANZ PTY LTD |
Acute myeloid leukaemia |
Jul 2024 |
Recommended |
| TALAZOPARIB |
Talzenna® |
PFIZER AUSTRALIA PTY LTD |
Prostate cancer (PC) |
Jul 2024 |
Recommended |
| PRASUGREL |
Prasugrel SCP |
GENERIC HEALTH PTY LTD |
Acute coronary syndrome |
Jul 2024 |
Recommended |
| LEVODOPA WITH CARBIDOPA AND ENTACAPONE |
Lecigon® |
STADA PHARMACEUTICALS AUSTRALIA PTY LIMITED |
Advanced Parkinson disease |
Jul 2024 |
Recommended |
| RAVULIZUMAB |
Ultomiris® |
ALEXION PHARMACEUTICALS AUSTRALASIA PTY LTD |
Generalised myasthenia gravis (gMG) |
Jul 2024 |
Not Recommended |
| MORPHINE |
Anamorph® |
ARROW PHARMA PTY LTD |
Severe pain, cancer pain, severe disabling pain |
Jul 2024 |
Recommended |